The Ensign Group, Inc. is a healthcare company.
The Ensign Group, Inc. (ENSG) is expected to report earnings on Monday, November 2, 2026, after the close. Estimated release time 16:11 ET. Consensus EPS estimate is $1.92.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-27 | FY2026 Q2 | $1.80 | $1.72 | -4.4% | $1.44B |
| 2026-04-30 | FY2026 Q1 | $1.82 | $1.73 | -4.9% | $1.39B |
| 2026-02-04 | FY2025 Q4 | $1.75 | $1.66 | -5.1% | $1.36B |
| 2025-11-03 | FY2025 Q3 | $1.59 | $1.46 | -8.2% | $1.30B |
| 2025-07-24 | FY2025 Q2 | $1.55 | $1.48 | -4.5% | $1.23B |
| 2025-04-29 | FY2025 Q1 | $1.49 | $1.41 | -5.4% | $1.17B |
| 2025-02-05 | FY2024 Q4 | $1.47 | $1.40 | -4.8% | $1.13B |
| 2024-10-24 | FY2024 Q3 | $1.38 | $1.38 | +0.0% | $1.08B |
ENSG has beaten consensus EPS in 1 of its last 8 reported quarters.
ENSG reported Jul 27. The highlights: EPS of $1.72 — a miss vs the $1.80 estimate (-4%); revenue of $1.44B — in line with the $1.44B consensus. Focus now shifts to occupancy and acquisitions.
ENSG pays a quarterly dividend, currently yielding 0.16%.
| Ex-dividend date | Amount | Paid |
|---|---|---|
| 2026-06-30 | $0.065 | 2026-07-31 |
| 2026-03-31 | $0.065 | 2026-04-30 |
| 2025-12-31 | $0.065 | 2026-01-31 |
| 2025-09-30 | $0.0625 | 2025-10-31 |
| 2025-06-30 | $0.0625 | 2025-07-31 |
| 2025-03-31 | $0.0625 | 2025-04-30 |